Tumor uptake of EV-F(ab′)2 in the low nectin-4–expressing MDA-MB-231 model was minimal (1.53 ± 0.35 %ID/g, P < 0.005) compared with MDA-MB-468 and BT474, confirming nectin-4–specific targeting. This evidence concerns the gene NECTIN4 and neoplasm.